Clinical Trials
4 trialsNCT05150353 2026-06-04
AMYLOCARP
Ramsay Générale de Santé
Phase NA Completed
NCT06745583 2026-06-03
A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Phase 2 Recruiting
NCT06804837 2026-06-03
Implement and Test Visual Consent Template and Process
Washington University School of Medicine
Phase NA Terminated
NCT07102212 2026-05-18
FOCUS
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting